The effect of intraovarian injection of platelet-rich plasma on ovarian morphology and insulin resistance in polycystic ovary syndrome (PCOS) rats

Sarvestani, Mojtaba; Rajabzadeh, Alireza; Ghavipanjeh, Gholamreza; Mazoochi, Tahereh; Salimian, Morteza

doi:10.48307/FMSJ.2024.28.2.123

[Home ] [Archive]

[ فارسی ]

Main Menu

Home

Journal Information

Indexing Sources

Guide for Authors

Online Submission

Ethics

Articles archive

For Reviewers

Contact us

Basic and Clinical Biochemistry and Nutrition

DOAJ

CINAHL

EBSCO

IMEMR

ISC

Search in website

Receive site information

enamad

Volume 28, Issue 2 (Bimonthly 2024)

Feyz Med Sci J 2024, 28(2): 123-131

Back to browse issues page

The effect of intraovarian injection of platelet-rich plasma on ovarian morphology and insulin resistance in polycystic ovary syndrome (PCOS) rats

Mojtaba Sarvestani

, Alireza Rajabzadeh

, Gholamreza Ghavipanjeh ^*

, Tahereh Mazoochi

, Morteza Salimian

Physiology Research Center, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran , rghp2017@gmail.com

Abstract: (1266 Views)

Background and Aim: Polycystic ovary syndrome (PCOS) is a multifaceted endocrine and infertility disorder characterized by symptoms such as insulin resistance, hyperandrogenism, anovulation, and ovarian cysts. This study aimed to examine the effect of intraovarian injection of platelet-rich plasma (PRP) on ovarian morphology and insulin resistance in a PCOS rat model.
Methods: In this experimental study, 20 Wistar rats were divided into four groups (N=5): control, sham, PCOS, and PCOS group treated with PRP. PCOS was induced using 1 mg/kg of letrozole dissolved in 0.5% carboxymethyl cellulose. The PRP group received 35 microliters of PRP injected directly into both ovaries. After 14 days of treatment, serum insulin levels, blood glucose, and the insulin resistance index (HOMA-IR) were measured. Ovarian tissue sections were also examined for histopathological changes and follicle count.
Results: Intraovarian injection of PRP led to a significant decrease in serum insulin levels (P<0.01) and glucose levels (P<0.01) compared to the PCOS group. The PRP-treated groups exhibited a significant reduction in the insulin resistance index (HOMA-IR) (P<0.0001). Histological analysis demonstrated that a single dose of PRP improved the ovarian pathological condition, resulting in a significant increase in healthy follicles at all developmental stages and corpus luteum (P<0.0001), along with a significant decrease in cystic follicles (P<0.0001).
Conclusion: Intraovarian PRP injection may ameliorate PCOS symptoms, including ovarian morphology and insulin resistance. However, further studies are necessary to elucidate the underlying mechanisms of PRP's effectiveness.

Keywords: Polycystic ovary syndrome, Platelet-rich plasma, Insulin resistance, Rat

Full-Text [PDF 502 kb] (837 Downloads)

Type of Study: Research | Subject: medicine, paraclinic
Received: 2024/02/8 | Revised: 2024/08/18 | Accepted: 2024/05/19 | Published: 2024/06/2

References

1. Gomaa MA, Desoky AA, Amer D, Alaa D, Khalil MA. Impulsivity, depression, and suicide in female patients with polycystic ovary syndrome and infertility. Middle East Curr Psychiatry. 2023; 30(1): 116. doi:10.1186/s43045-023-00386-2

2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81(1): 19-25. doi:10.1016/j.fertnstert.2003.10.004 PMid:14711538

3. Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013; 6:1-13. doi:10.2147/CLEP.S37559 PMid:24379699 PMCid:PMC3872139

4. Liao B, Qiao J, Pang Y. Central Regulation of PCOS: Abnormal Neuronal-Reproductive-Metabolic Circuits in PCOS Pathophysiology. Front Endocrinol (Lausanne). 2021; 12: 667422. doi:10.3389/fendo.2021.667422 PMid:34122341 PMCid:PMC8194358

5. Tabassum R, Imtiaz F, Sharafat S, Shukar-Ud-Din S, Nusrat U. Prevalence and clinical profile of insulin resistance in young women of poly cystic ovary syndrome: A study from Pakistan. Pak J Med Sci. 2013; 29(2): 593-6. doi:10.12669/pjms.292.3180 PMid:24353584 PMCid:PMC3809275

6. Zhao H, Zhang J, Cheng X, Nie X, He B. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res. 2023; 16(1): 9. doi:10.1186/s13048-022-01091-0 PMid:36631836 PMCid:PMC9832677

7. Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: What's new? Adv Clin Exp Med. 2017; 26(2): 359-67. doi:10.17219/acem/59380 PMid:28791858

8. Alves R, Grimalt R. A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification. Skin Appendage Disord. 2018; 4(1): 18-24. doi:10.1159/000477353 PMid:29457008 PMCid:PMC5806188

9. Yuan T, Zhang CQ, Wang JH. Augmenting tendon and ligament repair with platelet-rich plasma (PRP). Muscles Ligaments Tendons J. 2013; 3(3): 139-49. doi:10.32098/mltj.03.2013.05 PMid:24367773 PMCid:PMC3838322

10. Emer J. Platelet-Rich Plasma (PRP): Current Applications in Dermatology. Skin Therapy Lett. 2019; 24(5): 1-6.

11. Abdul Ameer LA, Raheem ZJ, Abdulrazaq SS, Ali BG, Nasser MM, Khairi AWA. The anti-inflammatory effect of the platelet-rich plasma in the periodontal pocket. Eur J Dent. 2018; 12(4): 528-31. doi:10.4103/ejd.ejd_49_18 PMid:30369798 PMCid:PMC6178670

12. Pavlovic V, Ciric M, Jovanovic V, Stojanovic P. Platelet Rich Plasma: a short overview of certain bioactive components. Open Med (Wars). 2016; 11(1): 242-7. doi:10.1515/med-2016-0048 PMid:28352802 PMCid:PMC5329835

13. Imam SS, Al-Abbasi FA, Hosawi S, Afzal M, Nadeem MS, Ghoneim MM, et al. Role of platelet rich plasma mediated repair and regeneration of cell in early stage of cardiac injury. Regen Ther. 2022; 19: 144-53. doi:10.1016/j.reth.2022.01.006 PMid:35229012 PMCid:PMC8856949

14. Zadehmodarres S, Salehpour S, Saharkhiz N, Nazari L. Treatment of thin endometrium with autologous platelet-rich plasma: a pilot study. JBRA Assist Reprod. 2017; 21 (1): 54-6. doi:10.5935/1518-0557.20170013 PMid:28333034 PMCid:PMC5365202

15. Davari Tanha F, Salimi Setudeh S, Ebrahimi M, Feizabad E, Khalaj Sereshki Z, Akbari Asbagh F, et al. Effect of intra-ovarian platelet rich plasma in women with poor ovarian response. Caspian J Intern Med. 2023; 14(3): 485-9.

16. Coksuer H, Akdemir Y, Ulas Barut M. Improved in vitro fertilization success and pregnancy outcome with autologous platelet-rich plasma treatment in unexplained infertility patients that had repeated implantation failure history. Gynecol Endocrinol. 2019;35(9):815-8. doi:10.1080/09513590.2019.1597344 PMid:30966843

17. Seyyed Anvari S, Dehgan GH, Razi M. Preliminary Findings of Platelet-Rich Plasma-Induced Ameliorative Effect on Polycystic Ovarian Syndrome. Cell J. 2019; 21(3): 243-52.

18. Mohammed S, Sundaram V, Zyuzikov N. Effect of 150 kHz electromagnetic radiation on the development of polycystic ovaries induced by estradiol Valerate in Sprague Dawley rats. J Ovarian Res. 2021; 14(1): 26. doi:10.1186/s13048-021-00774-4 PMid:33546719 PMCid:PMC7866699

19. Sadoughi S. Investigation the Effect of Curcumin on the Hormones of Pituitary-Ovarian Axis in Alloxan-induced Diabetic Rats. J Ardabil Univ Med Sci. 2016; 16(4): 441-51.

20. Wang J, Zhao Y, Zheng F, Ma N, Qin R, Qin W, et al. Activated Human Umbilical Cord Blood Platelet-Rich Plasma Enhances the Beneficial Effects of Human Umbilical Cord Mesenchymal Stem Cells in Chemotherapy-Induced POF Rats. Stem Cells Int. 2021; 2021: 8293699. doi:10.1155/2021/8293699 PMid:34733331 PMCid:PMC8560297

21. Li J, Yin FF, Hou YL. Early diagnosis of rats with acute myocardial infarction by measurement of brain natriuretic peptide. Exp Ther Med. 2013; 5(4): 1201-5. doi:10.3892/etm.2013.964 PMid:23596490 PMCid:PMC3627457

22. Ibrahim YF, Alorabi M, Abdelzaher WY, Toni NDM, Thabet K, Hegazy A, et al. Diacerein ameliorates letrozole-induced polycystic ovarian syndrome in rats. Biomed Pharmacother. 2022; 149: 1 12870. doi:10.1016/j.biopha.2022.112870 PMid:35367769

23. Farimani M, Nazari A, Mohammadi S, Anvari Aliabad R. Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: A retrospective study according to the POSEIDON criteria. Reprod Biol Endocrinol. 2021;19(1):137. doi:10.1186/s12958-021-00826-w

24. Lee WS, Otsuka F, Moore RK, Shimasaki S. Effect of bone morphogenetic protein-7 on folliculogenesis and ovulation in the rat. Biol Reprod. 2001; 65(4): 994-9. doi:10.1095/biolreprod65.4.994 PMid:11566718

25. Liu S, Jia Y, Meng S, Luo Y, Yang Q, Pan Z. Mechanisms of and Potential Medications for Oxidative Stress in Ovarian Granulosa Cells: A Review. Int J Mol Sci. 2023; 24(11). doi:10.3390/ijms24119205 PMid:37298157 PMCid:PMC10252376

26. Kakudo N, Morimoto N, Kushida S, Ogawa T, Kusumoto K. Platelet-rich plasma releasate promotes angiogenesis in vitro and in vivo. Med Mol Morphol. 2014; 47(2): 83-9. doi:10.1007/s00795-013-0045-9 PMid:23604952

27. Vo TKC, Tanaka Y, Kawamura K. Ovarian Rejuvenation Using Autologous Platelet-Rich Plasma. Endocrines. 2021; 2(1): 15-27. doi:10.3390/endocrines2010002

28. El-Tahawy NF. Effect of Platelet Rich Plasma (PRP) Injection on the Endocrine Pancreas of the Experimentally Induced Diabetes in Male Albino Rats: A Histological and Immunohistochemical Study. J Diabetes Metab. 2017;08. doi:10.4172/2155-6156.1000730

29. Nemati M, Karbalaei N, Mokarram P, Dehghani F. Effects of platelet-rich plasma on the pancreatic islet survival and function, islet transplantation outcome and pancreatic pdx(1) and insulin gene expression in streptozotocin-induced diabetic rats. Growth Factors. 2020; 38(3-4): 137-51. doi:10.1080/08977194.2021.1881502 PMid:33569978

30. Inoki K, Haneda M, Maeda S, Koya D, Kikkawa R. TGF-β1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells. Kidney International. 1999;55(5):1704-12. doi:10.1046/j.1523-1755.1999.00438.x PMid:10231432

31. Fidler TP, Marti A, Gerth K, Middleton EA, Campbell RA, Rondina MT, et al. Glucose Metabolism Is Required for Platelet Hyperactivation in a Murine Model of Type 1 Diabetes. Diabetes. 2019;68(5):932-8. doi:10.2337/db18-0981 PMid:30765335 PMCid:PMC6477909

32. Fan L, Ding L, Lan J, Niu J, He Y, Song L. Fibroblast Growth Factor-1 Improves Insulin Resistance via Repression of JNK-Mediated Inflammation. Front Pharmacol. 2019; 10. doi:10.3389/fphar.2019.01478 PMid:31866871 PMCid:PMC6906192

33. Wang L, Hayashi H, Ebina Y. Transient Effect of Platelet-derived Growth Factor on GLUT4 Translocation in 3T3-L1 Adipocytes. J Biol Chem. 1999; 274(27): 19246-53. doi:10.1074/jbc.274.27.19246 PMid:10383432

34. Giustina A, Berardelli R, Gazzaruso C, Mazziotti G. Insulin and GH-IGF-I axis: endocrine pacer or endocrine disruptor? Acta Diabetol. 2015;52(3):433-43. doi:10.1007/s00592-014-0635-6 PMid:25118998

35. Bertola A, Bonnafous S, Cormont M, Anty R, Tanti JF, Tran A, et al. Hepatocyte Growth Factor Induces Glucose Uptake in 3T3-L1 Adipocytes through A Gab1/Phosphatidylinositol 3-Kinase/Glut4 Pathway. J Biol Chem. 2007;282(14):10325-32. doi:10.1074/jbc.M611770200 PMid:17284447

Send email to the article author

Add your comments about this article

‎ 10.48307/FMSJ.2024.28.2.123

Mendeley

Zotero

RefWorks

Sarvestani M, Rajabzadeh A, Ghavipanjeh G, Mazoochi T, Salimian M. The effect of intraovarian injection of platelet-rich plasma on ovarian morphology and insulin resistance in polycystic ovary syndrome (PCOS) rats. Feyz Med Sci J 2024; 28 (2) :123-131
URL: http://feyz.kaums.ac.ir/article-1-5120-en.html

This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.

Volume 28, Issue 2 (Bimonthly 2024)

Back to browse issues page

Persian site map - English site map - Created in 2.44 seconds with 46 queries by YEKTAWEB 4704